Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

NIH × Interventional × Lupus Nephritis × Clear all

Phase

Status

Sponsor Class

NIH 1 INDUSTRY 1

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 410 Lymphoma 304 Carcinoma, Non-Small-Cell Lung 262 Melanoma 255 Precursor Cell Lymphoblastic Leukemia-Lymphoma 250 Prostatic Neoplasms 245 Leukemia, Lymphocytic, Chronic, B-Cell 242 Leukemia, Myeloid, Acute 222 Lung Neoplasms 215 Colonic Neoplasms 209 Neoplasms 208 Lymphoma, Non-Hodgkin 207 Lymphoma, Large B-Cell, Diffuse 204 Leukemia 200 Lymphoma, Follicular 197 Multiple Myeloma 196 Colorectal Neoplasms 189 Rectal Neoplasms 188 Ovarian Neoplasms 184 Burkitt Lymphoma 179 Brain Neoplasms 171 Neoplasm Metastasis 166 Lymphoma, Mantle-Cell 163 Carcinoma, Renal Cell 163 Glioblastoma 161 Sarcoma 156 Pancreatic Neoplasms 146 Lymphoma, B-Cell, Marginal Zone 143 Unspecified Adult Solid Tumor, Protocol Specific 138 Gliosarcoma 133

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00447265 2013-02-12

Etanercept for the Treatment of Lupus Nephritis

National Institute of Allergy and Infectious Diseases (NIAID)

Phase 2 Terminated

1 enrolled 15 charts

Lupus Nephritis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡